Companies › BKHA

BKHA 10-K & 10-Q changes, risk factors and insider trading

Black Hawk Acquisition Corp (also BKHAR, BKHAU) · Nasdaq · Biological Products, (No Diagnostic Substances) · CIK 2000775 · All filings on SEC.gov

Everything below is quoted or computed from Black Hawk Acquisition Corp's public SEC filings. It is not a recommendation to buy or sell. Automated comparisons can contain errors; confirm with the original filing.

At a glance

0 / 0risk-factor paragraphs added / removed in latest 10-K
0new risk-factor headings
0Form 4 filings reporting open-market purchases (last 180 days)
0Form 4 filings reporting open-market sales (last 180 days)

Jump to: Annual report (10-K) · Quarterly report (10-Q) · Insider transactions · 13F holders

What changed in the latest 10-K

Comparing 10-K filed 2026-03-06 (period ending 2025-11-30) with 10-K filed 2025-02-07 (period ending 2024-11-30).

Risk Factors (10-K Item 1A)

0new paragraphs
0removed paragraphs
0reworded paragraphs
17 → 17words in section

The section in the latest 10-K reads in full:

As a smaller reporting company, we are not required to include risk factors in this Annual Report.

No wording changes found in this section.

Full comparison: every changed paragraph (0)

Green = added, red = removed. Unchanged paragraphs and tables are not shown. Read the complete text in the original filing.

Management's Discussion & Analysis (MD&A) (10-K Item 7)

2new paragraphs
2removed paragraphs
3reworded paragraphs
2,150 → 2,279words in section

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

Reworded

Paragraph as it now reads, with added and removed wording marked:

We are a blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.businesses WeOn haveApril not26, selected2025, anywe specificentered into a Business Combination Agreement with Vesicor Therapeutics, Inc. (“Vesicor”) and BH Merger Sub, Inc., pursuant to which we intend to consummate a business combination, subject to the satisfaction of customary closing conditions. The proposed transaction is described in greater detail elsewhere in this Annual Report and in our Registration Statement on Form S-4 filed with the SEC. There can be no assurance that the proposed business combination targetwill be and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target.consummated.
see in full comparison
New text
“The Company entered into an Administrative Services Agreement with the Sponsor on December 4, 2023, pursuant to which the Company pays the Sponsor a monthly fee of $10,000 for office space and administrative and support services. The agreement commenced on the effective date of the Company’s initial public offering registration statement and continues through the earlier of the consummation of the Company’s initial business combination or the Company’s liquidation. …”
see in full comparison
Reworded

Paragraph as it now reads, with added and removed wording marked:

UponIn closingconnection ofwith athe BusinessCompany’s Combination,initial public offering, the underwriters will beare entitled to a deferred feeunderwriting ofcommission equal to 3.5% of the gross proceeds of the IPO, or $2,415,000. The deferred feeunderwriting commission is payable solely upon the consummation of an initial business combination and will becomebe payable to the underwriterspaid from the amountsfunds held in the Trusttrust Account solely in the event that we complete a Business Combination,account, subject to the terms of the underwriting agreement. Additionally,If wethe Company does not consummate a business combination, the deferred underwriting commission will not be paid. In addition, the Company issued the underwriters 69,000 ordinary shares common stock, or the representative shares, at the closing of the IPO as part of representative compensation.
see in full comparison
Removed text
“The Company entered into an Administrative Services Agreement with the Sponsor on December 4, 2023, commencing on the effective date of the registration statement of IPO through the later of the Company’s consummation of a Business Combination or 21 months from such effective date, to pay the Sponsor a total of $10,000 per month for office space and administrative and support services.”
see in full comparison
New text
“For the year ended November 30, 2025, we had net income of $1,329,557, which consisted of interest income of $2,244,975, and change in fair value of derivative liability of $92, offset by general and administrative expenses of $795,510, and related party administrative fees of $120,000.”
see in full comparison
Removed text
“For the year ended November 30, 2023, we had net loss of $18,853, all of which consisted of formation and operating costs.”
see in full comparison
Full comparison: every changed paragraph (7)

Green = added, red = removed. Unchanged paragraphs, 3 paragraphs where only numbers/dates changed, and tables are not shown. Read the complete text in the original filing.

Reworded

We are a blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.businesses WeOn haveApril not26, selected2025, anywe specificentered into a Business Combination Agreement with Vesicor Therapeutics, Inc. (“Vesicor”) and BH Merger Sub, Inc., pursuant to which we intend to consummate a business combination, subject to the satisfaction of customary closing conditions. The proposed transaction is described in greater detail elsewhere in this Annual Report and in our Registration Statement on Form S-4 filed with the SEC. There can be no assurance that the proposed business combination targetwill be and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target.consummated.

Added

For the year ended November 30, 2025, we had net income of $1,329,557, which consisted of interest income of $2,244,975, and change in fair value of derivative liability of $92, offset by general and administrative expenses of $795,510, and related party administrative fees of $120,000.

Removed

For the year ended November 30, 2023, we had net loss of $18,853, all of which consisted of formation and operating costs.

Reworded

As of November 30, 2024,2025, we had cash of $264,842$39,521 and a working capital deficit of $243,093.$1,431,443. The Company’s liquidity needs prior to the consummation of the IPO had been satisfied through a payment from the Sponsor of $25,000 for the Founder Shares and the loan under an unsecured promissory note from the Sponsor of $250,000. Subsequent to the consummation of the IPO, the Company expects that it will need additional capital to satisfy its liquidity needs beyond the net proceeds from the consummation of the IPO and the proceeds held outside of the Trust Account for paying existing accounts payable, identifying and evaluating prospective business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Initial Business Combination. Although certain of the Company’s initial shareholders, officers and directors or their affiliates have committed to loan the Company funds from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, there is no guarantee that the Company will receive such funds.

Added

The Company entered into an Administrative Services Agreement with the Sponsor on December 4, 2023, pursuant to which the Company pays the Sponsor a monthly fee of $10,000 for office space and administrative and support services. The agreement commenced on the effective date of the Company’s initial public offering registration statement and continues through the earlier of the consummation of the Company’s initial business combination or the Company’s liquidation. The Sponsor is not obligated to provide services beyond the term of the agreement, and the Company may terminate the agreement upon completion of a business combination.

Removed

The Company entered into an Administrative Services Agreement with the Sponsor on December 4, 2023, commencing on the effective date of the registration statement of IPO through the later of the Company’s consummation of a Business Combination or 21 months from such effective date, to pay the Sponsor a total of $10,000 per month for office space and administrative and support services.

Reworded

UponIn closingconnection ofwith athe BusinessCompany’s Combination,initial public offering, the underwriters will beare entitled to a deferred feeunderwriting ofcommission equal to 3.5% of the gross proceeds of the IPO, or $2,415,000. The deferred feeunderwriting commission is payable solely upon the consummation of an initial business combination and will becomebe payable to the underwriterspaid from the amountsfunds held in the Trusttrust Account solely in the event that we complete a Business Combination,account, subject to the terms of the underwriting agreement. Additionally,If wethe Company does not consummate a business combination, the deferred underwriting commission will not be paid. In addition, the Company issued the underwriters 69,000 ordinary shares common stock, or the representative shares, at the closing of the IPO as part of representative compensation.

What changed in the latest 10-Q

Comparing 10-Q filed 2026-10-06 (period ending 2026-08-31) with 10-Q filed 2026-07-15 (period ending 2026-05-31).

Risk Factors (10-Q Part II, Item 1A)

0new paragraphs
0removed paragraphs
0reworded paragraphs
15 → 15words in section

The section in the latest 10-Q reads in full:

As a smaller reporting company, we are not required to make disclosures under this Item.

No wording changes found in this section.

Full comparison: every changed paragraph (0)

Green = added, red = removed. Unchanged paragraphs and tables are not shown. Read the complete text in the original filing.

Management's Discussion & Analysis (MD&A) (10-Q Part I, Item 2)

21new paragraphs
2removed paragraphs
16reworded paragraphs
3,957 → 5,641words in section

New heading “Forward Purchase Agreement”

New heading “Non-Redemption Agreement”

New heading “Subscription Agreement”

New heading “Standby Equity Purchase Agreement”

New heading “Registration Rights Agreement”

New heading “Change in Fair Value of Derivative Liability”

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

New text topics: delist
“Unless extended by mutual written consent, the valuation date under the Forward Purchase Agreement will occur 36 months after the closing of the Business Combination, subject to acceleration upon certain delisting or registration-failure events. …”
see in full comparison
New text topics: default
“The SEPA also permits the parties, by mutual written agreement and subject to specified conditions, to enter into one or more pre-paid advances evidenced by convertible promissory notes. Each such pre-paid advance would be funded at 85% of the face amount of the applicable note, reflecting a 15% original issue discount. …”
see in full comparison
Reworded topics: delist

Paragraph as it now reads, with added and removed wording marked:

On March 31, 2026, the Company received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company’s market value of listed securities (“MVLS”) had been below the $50,000,000 minimum required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) for the previous 30 consecutive business days. The notice provides the Company with 180 calendar days, or until September 28, 2026, to regain compliance. To regain compliance, the Company’s MVLS must close at $50,000,000 or more for a minimum of ten consecutive business days, subject to Nasdaq’s discretion. TheOn noticeAugust does17, not2026, resultNasdaq innotified Black Hawk that, for the immediate10 consecutive business days from August 3, 2026 through August 14, 2026, Black Hawk’s MVLS had been $50,000,000 delistingor ofgreater. the Company’s securities, which continue to trade on theAccordingly, Nasdaq Globaldetermined Marketthat underBlack theHawk symbolshad “BKHAU,” “BKHA,”regained compliance with Nasdaq Listing Rule 5450(b)(2)(A) and “BKHAR.” Ifthat the matter Companywas does not regain compliance by the applicable deadline, the Company may be subject to delisting, although it may appeal any such determination or apply to transfer the listing of its securities to the Nasdaq Capital Market, subject to satisfaction of applicable requirements.closed.
see in full comparison
New text
“Change in Fair Value of Derivative Liability”
see in full comparison
New text
“Standby Equity Purchase Agreement”
see in full comparison
New text
“Registration Rights Agreement”
see in full comparison
Full comparison: every changed paragraph (39)

Green = added, red = removed. Unchanged paragraphs and tables are not shown. Read the complete text in the original filing.

Reworded

We are a blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target.

Reworded

The Transaction, which has been approved unanimously by the boards of directors of both Black Hawk and Vesicor, is subject to regulatory approvals, the approvals by the shareholders of Black Hawk and Vesicor, respectively, and the satisfaction of certain other customary closing conditions including the approval by Nasdaq of the listing application of the combined company. The Registration Statement on Form S-4 relating to the proposed Business Combination was declared effective by the SEC on September 17, 2026. On September 22, 2026, the Company filed its definitive proxy statement/prospectus. The Business Combination is expected to be completed by the thirdfourth quarter of 2026.

Removed

On March 4, 2026, the Company filed Amendment No. 3 to its Registration Statement on Form S-4 relating to the proposed Business Combination, and there can be no assurance as to the timing of completion or that the Business Combination will be completed at all.

Reworded

On March 31, 2026, the Company received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company’s market value of listed securities (“MVLS”) had been below the $50,000,000 minimum required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) for the previous 30 consecutive business days. The notice provides the Company with 180 calendar days, or until September 28, 2026, to regain compliance. To regain compliance, the Company’s MVLS must close at $50,000,000 or more for a minimum of ten consecutive business days, subject to Nasdaq’s discretion. TheOn noticeAugust does17, not2026, resultNasdaq innotified Black Hawk that, for the immediate10 consecutive business days from August 3, 2026 through August 14, 2026, Black Hawk’s MVLS had been $50,000,000 delistingor ofgreater. the Company’s securities, which continue to trade on theAccordingly, Nasdaq Globaldetermined Marketthat underBlack theHawk symbolshad “BKHAU,” “BKHA,”regained compliance with Nasdaq Listing Rule 5450(b)(2)(A) and “BKHAR.” Ifthat the matter Companywas does not regain compliance by the applicable deadline, the Company may be subject to delisting, although it may appeal any such determination or apply to transfer the listing of its securities to the Nasdaq Capital Market, subject to satisfaction of applicable requirements.closed.

Reworded

On June 30, 2026, Black Hawk and Vesicor entered into a Debt Forgiveness Agreement pursuant to which Vesicor forgave $1,015,988 in advances previously made by Vesicor to or on behalf of Black Hawk (the “Vesicor Advances”). as of February 12, 2026. The Vesicor Advances consisted of (i) $675,000 in extension payment advances made between July 2025 and February 2026, representing Vesicor’s one-half share of the monthly $150,000 trustTrust fund Account extension payments required under the Business Combination Agreement and the amended Trust Agreement, and (ii) $340,987.50$340,988 in upfront fee payments and other transaction expenses paid by Vesicor on Black Hawk’s behalfbehalf, betweenincluding Marchthe andtwo April$125,000 2025non-refundable fordeposits previously upfrontpaid feesto andthe FebruaryCompany 2026in for otherconnection transactionwith expenses.the proposed transaction. All advances included in the Debt Forgiveness Agreement were made on a non-interest basis.

Reworded

Pursuant to the Debt Forgiveness Agreement, Vesicor (i) forgave the entire outstanding principal amount of the Vesicor Advances,Advances as of February 12, 2026, (ii) agreed that all debt instruments issued or issuable in connection with the Vesicor Advances are null and void, and (iii) waived and cancelled any rights to convert the Vesicor Advances into debt or equity securities of Black Hawk or any successor. Vesicor’s forgiveness of advances classified as upfront fees was made pursuant to a waiver, consent and authorization of Vesicor’s shareholders. Any advances made by Vesicor after February 12, 2026 are expressly excluded from the Debt Forgiveness AgreementAgreement. and will be governed byNo separate written agreements betweengoverning thethose parties.post-February 12, 2026 advances had been entered into as of October 6, 2026.

Added

On September 17, 2026, the Registration Statement on Form S-4 relating to the proposed business combination was declared effective by the SEC. The Company filed its definitive proxy statement/prospectus on September 22, 2026 and scheduled an extraordinary general meeting for the shareholders which will be held at 10:00 a.m. Eastern Time, on October 13, 2026.

Added

On September 22, 2026, an aggregate of $150,000 (the “Extension Payment”) has been deposited into the trust account for its public shareholders, which enables the Company to further extend the period of time it has to consummate its initial business combination by one month from September 22, 2026 to October 22, 2026.

Added

On September 22, 2026, Black Hawk and Vesicor entered into a series of financing and related agreements with Meteora Select Trading Opportunities Master, LP (“Meteora”) in connection with the Company’s previously announced business combination with Vesicor. Pursuant to the Business Combination Agreement dated April 26, 2025, the Company will domesticate as a Delaware corporation and change its name to “Vesicor Therapeutics Holdings, Inc.” (“PubCo”), and Vesicor will become a wholly owned subsidiary of PubCo.

Added

Forward Purchase Agreement

Added

On September 22, 2026, the Company, Vesicor and Meteora entered into an OTC Equity Prepaid Forward Transaction confirmation (the “Forward Purchase Agreement”). The Forward Purchase Agreement provides for a share forward transaction with respect to up to 1,350,000 shares (the “Maximum Number of Shares”), subject to an upward adjustment upon the occurrence of certain dilutive offerings. The shares subject to the transaction may consist of (i) shares purchased by Meteora from third parties in the open market for which Meteora irrevocably waives redemption rights (“Recycled Shares”) and (ii) shares purchased directly from the Company pursuant to the Subscription Agreement described below (“Additional Shares”). The aggregate number of Recycled Shares and Additional Shares may not exceed the Maximum Number of Shares.

Added

The initial price under the Forward Purchase Agreement will equal the per-share redemption price payable to holders of the Company’s public ordinary shares in connection with the Business Combination (the “Initial Price”). Subject to receipt of the applicable pricing date notice, at or in connection with the closing of the Business Combination the Company will pay Meteora, from the trust account, a prepayment amount equal to the number of shares specified in the pricing date notice multiplied by the Initial Price, reduced dollar-for-dollar by the aggregate purchase price funded by Meteora for any Additional Shares under the Subscription Agreement. The reset price will initially be $10.00 per share and may be reduced by mutual written agreement or upon certain dilutive offerings.

Added

Unless extended by mutual written consent, the valuation date under the Forward Purchase Agreement will occur 36 months after the closing of the Business Combination, subject to acceleration upon certain delisting or registration-failure events. Following the end of a valuation period commencing on the valuation date, Meteora will pay the Company in cash an amount equal to the number of shares then remaining subject to the transaction (excluding terminated shares and any shares not then registered for resale or freely tradable under Rule 144) multiplied by the volume-weighted average price of the shares over that valuation period, and Meteora will not be required to return any portion of the prepayment amount. Meteora may elect to terminate the transaction in whole or in part prior to the valuation date, in which case Meteora will pay the Company an amount equal to the number of terminated shares multiplied by the then-current reset price. The Forward Purchase Agreement also requires PubCo to file, within 30 calendar days after the closing of the Business Combination, a registration statement covering the resale of the Additional Shares and to use commercially reasonable efforts to cause such registration statement to become effective within the periods specified therein. The Company also agreed to reimburse certain documented legal and out-of-pocket expenses of Meteora, subject to the aggregate $75,000 cap described below.

Added

Non-Redemption Agreement

Added

On September 22, 2026, the Company and Meteora entered into a Non-Redemption Agreement (the “Non-Redemption Agreement”). Pursuant to the Non-Redemption Agreement, Meteora agreed, on a commercially reasonable best-efforts basis and subject to the terms thereof, to beneficially own and not redeem, or to reverse previously submitted redemption requests with respect to, up to 2,124,077 of the Company’s ordinary shares (the “Backstop Investor Shares”). The number of Backstop Investor Shares is a maximum and does not constitute an obligation of Meteora to acquire or hold any minimum number of shares.

Added

Immediately upon the closing of the Business Combination, the Company will pay Meteora cash from the trust account in respect of the Backstop Investor Shares, being, in respect of each Backstop Investor Share, an amount equal to the final per-share redemption price less $0.75. The Non-Redemption Agreement provides that Meteora will deliver a share confirmation notice after the redemption deadline specifying the actual number of Backstop Investor Shares, not to exceed 2,124,077 shares. The Non-Redemption Agreement terminates upon the occurrence of certain specified events, subject to the survival provisions set forth therein.

Added

Subscription Agreement

Added

In connection with the Forward Purchase Agreement, on September 22, 2026, the Company and Meteora entered into a Subscription Agreement (the “Subscription Agreement”), pursuant to which Meteora agreed to purchase from the Company, as Additional Shares, a number of shares equal to the Maximum Number of Shares under the Forward Purchase Agreement less the number of Recycled Shares, at a per-share purchase price equal to the Initial Price, subject to the terms and conditions of the Subscription Agreement and the Forward Purchase Agreement. Meteora will not be required to purchase Additional Shares to the extent that, after giving effect to the issuance, its ownership would exceed 9.9% of the outstanding shares, unless Meteora waives such limitation in its sole discretion. The initial purchase of Additional Shares, if any, is expected to occur substantially concurrently with, but not before, the closing of the Business Combination, with any additional purchases occurring thereafter in accordance with the Forward Purchase Agreement.

Added

Standby Equity Purchase Agreement

Added

On September 22, 2026, the Company, Vesicor and Meteora also entered into a Standby Equity Purchase Agreement (the “SEPA”), pursuant to which, following the effectiveness of the registration statement required by the related Registration Rights Agreement described below and subject to the satisfaction of the conditions set forth in the SEPA, PubCo will have the right, but not the obligation, to sell to Meteora up to $200.0 million of shares of PubCo common stock from time to time during a commitment period generally lasting 36 months, which may be extended by up to 24 months by mutual written agreement. There is no mandatory minimum utilization amount and no non-usage fee.

Added

For ordinary advances under the SEPA, the purchase price will generally equal 97% of the applicable market price determined in accordance with one of two pricing periods selected by PubCo, subject to the limitations and adjustments set forth in the SEPA. The maximum amount of each advance generally may not exceed 30% of the average daily traded amount during the 10 consecutive trading days preceding the applicable advance notice, unless otherwise agreed. The SEPA is also subject to a beneficial ownership limitation initially equal to 4.9%, which Meteora may elect to increase up to 9.9%, and to applicable Nasdaq issuance limitations unless stockholder approval or another exception is available.

Added

The SEPA also permits the parties, by mutual written agreement and subject to specified conditions, to enter into one or more pre-paid advances evidenced by convertible promissory notes. Each such pre-paid advance would be funded at 85% of the face amount of the applicable note, reflecting a 15% original issue discount. The form of convertible promissory note provides for a 12-month maturity, 0% annual interest absent an event of default (increasing to 18% during an uncured event of default), a 7% payment premium on principal amounts paid in circumstances specified in the note, and conversion at the lower of a fixed-price formula and 95% of the lowest daily VWAP during the five trading days preceding the applicable conversion or determination date, subject to a floor price and other adjustments. No pre-paid advance is required to be funded unless the Company and Meteora mutually agree in writing.

Added

As consideration for Meteora’s commitment under the SEPA, PubCo will pay Meteora a commitment fee equal to 0.50% of the $200.0 million maximum commitment amount, payable, at PubCo’s election, in cash or shares of PubCo common stock valued as provided in the SEPA. The Company also agreed to reimburse Meteora for reasonable and documented transaction expenses, subject to an aggregate cap of $75,000 shared among the SEPA, the Forward Purchase Agreement and the Non-Redemption Agreement.

Added

Registration Rights Agreement

Added

On September 22, 2026, the Company and Meteora entered into a Registration Rights Agreement (the “Registration Rights Agreement”) relating to securities issuable under the SEPA and any convertible promissory notes issued thereunder. The Registration Rights Agreement requires PubCo to file an initial resale registration statement no later than 60 calendar days following the closing of the Business Combination and to use commercially reasonable efforts to have such registration statement declared effective no later than 60 calendar days following its filing, subject to the terms of the Registration Rights Agreement. The initial registration statement is required to cover at least the greater of 10,000,000 shares of PubCo common stock and 300% of the maximum number of shares issuable upon conversion of all then-outstanding promissory notes, subject to applicable SEC limitations and the terms of the Registration Rights Agreement. Certain failures to timely file or obtain effectiveness, or to maintain the availability of the registration statement, may result in specified remedies, including partial liquidated damages based on outstanding note principal.

Removed

In consideration for the foregoing, Black Hawk released Vesicor from any claims arising from Vesicor’s failure to timely advance or pay any portion of the Vesicor Advances or otherwise timely perform its obligations under the Business Combination Agreement. Each party retained all other rights and claims under the Business Combination Agreement not expressly released. The Debt Forgiveness Agreement is governed by the laws of the State of California.

Reworded

We have neither engaged in any operations nor generated any revenues to date. Our only activities from September 28, 2023 (inception) through MayAugust 31, 2026, were organizational activities and those necessary to consummate the IPO, and subsequent to the IPO, identifying a target company for an initial business combination. We do not expect to generate any operating revenues until after the completion of our initial business combination.

Reworded

For the three months ended MayAugust 31, 2026, we had net income of $88,929,$1,074,736, which consisted of general and administrative expenses of $79,215,$108,210, related party administrative fees of $30,000, interest expense of $24,381,$33,226, offset by interest income of $222,525.$230,184 and gain on Debt Forgiveness of $1,015,988.

Reworded

For the sixnine months ended MayAugust 31, 2026, we had net income of $228,734,$1,303,470, which consisted of general and administrative expenses of $103,403,$211,613, related party administrative fees of $60,000, $90,000, interest expense of $43,830,$77,056, offset by interest income of $435,967.$666,151 and gain on Debt Forgiveness of $1,015,988.

Reworded

For the three months ended MayAugust 31, 2025, we had net income of $520,542,$154,401, which consisted of general and administrative expenses of $217,598,$311,265, related party administrative fees of $30,000, offset by interest income of $768,140.$494,562 and a decrease in fair value of derivative liability of $1,104.

Reworded

For the sixnine months ended MayAugust 31, 2025, we we had net income of $1,178,921,$1,333,322, which consisted of general and administrative expenses of $296,367,$607,632, and related party administrative fees fees of $60,000,$90,000, offset by interest income of $1,535,288.$2,029,850 and a decrease in fair value of derivative liability of $1,104.

Added

Change in Fair Value of Derivative Liability

Added

For both the three and nine month periods ended August 31, 2025, the Company recognized a $1,104 non-cash gain from the change in fair value of the derivative liability associated with the Sponsor’s Convertible Note. This liability reflects the fair value of the embedded conversion feature, measured using a binomial tree model in accordance with ASC 820, Fair Value Measurement. Upon the modification of the Convertible Notes on September 30, 2025, the conversion feature was revised such that it met the equity scope exception under ASC 815-40. As a result, the embedded derivative no longer required separate liability classification. The carrying amount of the derivative liability as of the modification date was reclassified to additional paid-in capital.

Reworded

As of MayAugust 31, 2026, we had cash of $11,583$12,052 and and a working capital deficit of $2,688,676.$2,294,124. The Company’s liquidity needs prior to the consummation of the IPO had been satisfied through through a payment from the Sponsor of $25,000 for the Founder Shares and the loan under an unsecured promissory note from the Sponsor of $250,000. Subsequent to the consummation of the IPO, the Company expects that it will need additional capital to satisfy its liquidity needs beyond the net proceeds from the consummation of the IPO and the proceeds held outside of the Trust Account for paying existing accounts payable, identifying and evaluating prospective business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Initial Business Combination. Although certain of the Company’s initial shareholders, officers and directors or their affiliates have committed to loan the Company funds from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, there is no guarantee that the Company will receive such funds.

Reworded

The Company has incurred and expects to continue to incur significant professional costs to remain as a publicly traded company and to incur incur significant transaction costs in pursuit of the consummation of a Business Combination. In connection with the Company’s assessment assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern. In addition, if the Company is unable to complete a Business Combination within the Combination Period, the Company’s board of directors would proceed to commence voluntary liquidation and thereby a formal dissolution of the Company. There is no assurance that the Company’s plans to consummate a Business Combination will be successful within the Combination Period. As a result, management has determined that such an additional condition also raises substantial doubt about the Company’s ability to continue as a going concern. The unaudited consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Reworded

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of MayAugust 31, 2026. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Reworded

The preparation of unaudited consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have not identified any critical accounting policies and estimates.

Reworded

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited consolidated financial statements.

Reworded

As of MayAugust 31, 2026, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not have any commitments or contractual obligations.

BKHA insider buying and selling (Form 4)

Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.

No Form 4 stock transactions in this period.

Well-known investors holding BKHA (13F)

InvestorQuarterSharesReported value% of their 13FChange vs prior quarter
D. E. Shaw & Co. USD CL A SHS2026-06-3075,000$882.8K0.0%No change
D. E. Shaw & Co. RIGHT 06/20/20252026-06-3015,000$23.1K0.0%No change

13F reports are filed up to 45 days after quarter end and show long U.S. equity positions only; options positions are omitted here.

Coming soon: email alerts when BKHA files, watchlists and downloadable comparisons.